This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



 




NSH NEWS

Get connected: NSH S/C Live Webinar Series
NSH
Can't join us in DC for the Annual Symposium/Convention? You can, but others from your lab can't? We have an option for you. The National Society for Histotechnology has selected six convention workshops to broadcast live via webinar during the convention. This series gives histology professionals who cannot attend the live event a chance to experience some of the education offered during the week. Check out what is available!
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




Volunteer opportunities at the NSH Symposium/Convention
NSH
The NSH Symposium/Convention is a large event and requires all hands on deck to be successful. Volunteering is a great way to get involved in NSH and be a part of NSH's premier educational event. NSH awards up to two contact hours per year for volunteering at NSH events or on NSH projects. Volunteers that participate in any tasks listed below will be eligible for two volunteer contact hours in 2015. Volunteers will be required to attend an orientation webinar at the beginning of August. If you are able to assist in any of the following positions, Registration Desk, Convention Guides, Career Day, Social Networking, Workshop Ambassadors, Convention Mentors, please click here and complete the sign up form.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


One-day forum on Immunohistochemistry — July 18
NSH
This all-day forum features advanced topics in the field of clinical immunohistochemistry and molecular diagnostics. The program includes "Case Studies in Diagnostic Immunohistochemistry" presented by Richard Cartun, MS, Ph.D., director, Histology & Immunopathology, Hartford Hospital. Cartun will present several surgical pathology cases demonstrating the use of new primary antibodies for diagnostic immunohistochemistry. In addition, pre-analytic (fixation and tissue processing), analytic (antigen retrieval and primary antibody dilutions), and post-analytic (interpretation) issues will be covered as well. Cartun is a dynamic speaker who welcomes active audience participation. The program also includes a scheduled question and answer period at the end of each presentation.

To review the other presentations and to register please click here.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
  GBI Cost Effective Products

GBI Labs produces the largest selection of secondary detection kits, from single to multiple detection kits, with wide range host species. We provide FREE samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market with 20%-30% cost less.
 


TOP STORIES


How wearable electronics will change clinical trials
Clinical Leader
Advances in sensor technology and microelectronics have opened new opportunities in the health and life sciences industries. Wearable sensors allow for continuous bio-monitoring without any manual intervention, thus reducing provider-patient interaction and costs while contributing improvements in the quality of the data.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New Alzheimer disease study makes connection to cause
The Huffington Post
Dealing with Alzheimer disease is one of the most frustrating, heartbreaking ordeals a family has to go through in life. And Alzheimer researchers have had their own level of frustration as well. There are no viable therapies, so only 45 percent of patients are even told they have it, and it's proven to be one of the most complex disease there is. Scientists say they don't know very much when it onsets and don't have a designed mechanism of what the process of the disease is. Could it be that all of that is about to change?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Diabetes: FDA approves use of vaccine for clinical trials to treat type 1 diabetes
Inquisitr
In the United States alone, 1.25 million people suffer from type 1 diabetes. A vaccine used over 100 years ago for tuberculosis (bacillus Calmette-Guerin ) has shown promise in reversing this disease. This vaccine is now commonly used for treating bladder cancer and is considered to be safe. An announcement made recently at the 75th Scientific Sessions of the American Diabetes Association said that the FDA will test the vaccine on 150 people who are in an advanced stage of type one diabetes.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Missed an issue of Under The Microscope? Click here to visit the Under The Microscope archive page.


For 2nd time in 3 years, OPKO Health will acquire a clinical lab company by spending $1.47 billion to acquire Bio-Reference Laboratories
Dark Daily
It's a big medical laboratory acquisition that has some experts on Wall Street shaking their heads. Recently, it was announced that OPKO Health Inc. of Miami, would pay $1.47 billion to acquire Bio-Reference Laboratories Inc., the nation's third largest full-service clinical laboratory. OPKO is a multinational biopharmaceutical and diagnostics company in Miami.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Hassle Free Block Storage Cabinet

Avantik Biogroup is proud to introduce another Customer Requested Quality Innovation for Histology...the Avantik Biogroup Block Storage Cabinet! We introduced Hassle-Free Drawer Technology with Interlocking Stackability and More Clearance between the top of the blocks and the drawers to achieve the industry's first Jam-Free, Hassle-Free Block Storage Cabinet!
 


IN THE NEWS


Risk-based monitoring: A more strategic approach to site monitoring and clinical data management
Clinical Leader
When executed properly, a risk-based monitoring approach to clinical trial monitoring can aid sponsors in allocating resources more effectively, reducing costs, saving time and improving data quality. Here's a closer look at the practice, its future, and what it could mean for the industry.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Researchers' discovery may explain difficulty in treating Lyme disease
Infection Control Today
Northeastern University researchers have found that the bacterium that causes Lyme disease forms dormant persister cells, which are known to evade antibiotics. This significant finding, they says, could help explain why it's so difficult to treat the infection in some patients. "It hasn't been entirely clear why it's difficult to treat the pathogen with antibiotics since there has been no resistance reported for the causative agent of the disease," explains professor Kim Lewis, who led the Northeastern research team.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Safer science
Lab Manager
A rash of serious incidents has brought the reality of this gulf to light in a tragic way. Issues span a variety of gaps, including organizational buy-in and accountability, oversight of safety programs, and weak or incomplete hazard evaluations. This article will take an in-depth look into these and other issues and discuss how you can avoid potentially serious shortfalls in your lab safety programs.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PhRMA's new principles on conducting clinical trials take effect
Outsourcing-Pharma.com
Recently, a new chapter of PhRMA's Principles on the Conduct of Clinical Trials and Communication of Clinical Trial Results went into effect, detailing efforts to raise awareness around expanded access programs, which provide investigational drugs for certain patients who are ineligible or unable to participate in a clinical trial.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Scientists find CJD resistance gene
BBC
Researchers have identified a gene that might make people resistant to the brain eating disease CJD. The study is part of an effort to find ways of combating a possible epidemic caused by eating BSE infected beef in the 1980s It is claimed that the findings could give important insight into other human brain diseases that lead to dementia.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Researchers find textbook-altering link between brain, immune system (Lab Manager)
ASCP opens 2015 wage survey (NSH)
Researchers discover a treatment to block MS progression (Drug Discovery & Development)
Mayo Clinic researchers determine use of high definition optical technology enables physicians to identify precancerous polyps immediately (Dark Daily)
Sustained growth in Medicare Advantage plans threatens financial health of smaller pathology groups and local medical labs (Dark Daily)

Don't be left behind. Click here to see what else you missed.


 

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
June 3, 2015
May 28, 2015 blast
May 27, 2015
May 20, 2015



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063